Last reviewed · How we verify
NCT03451747
The Potential Role of Testosterone on Target Organ Damage in Postmenopausal Hypertensive Women
trial in Hypertension in 322 participants. Status unknown.
5 April 2018
Quick facts
| Lead sponsor | LanZhou University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 322 |
| Start date | 10 March 2018 |
| Primary completion | 5 April 2018 |
| Estimated completion | 5 April 2018 |
Conditions studied
- Hypertension — all drugs for Hypertension →
Sponsor
LanZhou University
Who can join
Adults 45 to 65, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The incidence of CVD-related deaths is generally higher in women than men. Postmenopausal changes in estrogen/androgen ratio that induce a relative androgen excess have been proposed as important factors in the higher prevalence of hypertension. Therefore, the investigators hypothesize that testosterone has potential role between hypertension and target organ damage in postmenopausal hypertensive women. And the objective is to evaluate the effects of testosterone between hypertension and target organ damage in postmenopausal hypertensive women.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women.
Li N, Ma R, Wang S, Zhao Y, et al · · 2019 · cited 7× · PMID 31118595 · DOI 10.2147/cia.s195498 -
Correlation between ambulatory blood pressure indices and sex hormone imbalance in hypertensive women with different menopausal durations: a cross-sectional study.
Zhang S, Yu H, Jing C, Liang W, et al · · 2026 · PMID 41555389 · DOI 10.1186/s40001-025-03797-5 -
Correlation between Blunted Nocturnal Blood Pressure Decline and Sex Hormone Imbalance in Hypertensive Women with Different Menopausal Durations: A Cross-Sectional Study
Zhang S, Yu H, Jing C, Liang W, et al · · 2025 · DOI 10.21203/rs.3.rs-7760424/v1
Verify or expand the search:
- PubMed search for NCT03451747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other LanZhou University trials
Trials by the same sponsor.
- NCT07312370 — Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing · Phase 4 · not yet recruiting
- NCT07263867 — Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy · NA · not yet recruiting
- NCT07314554 — Recurrence After Gastric and Intestinal Polyp Resection · not yet recruiting
- NCT07286877 — Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients · NA · not yet recruiting
- NCT07234344 — A Predictive Model for Midwives' C F: A Cross-Sectional Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03451747 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LanZhou University
- Last refreshed: 5 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing